Jacques Hamon

Large-scale prediction and testing of drug activity on side-effect targets

Eugen Lounkine, Michael J. Keiser, Steven Whitebread et al. · Nature · 2012 · 897 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Pascal Furet, Vito Guagnano, Robin A. Fairhurst et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 470 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure

Andreas Bender, Josef Scheiber, Meir Glick et al. · ChemMedChem · 2007 · 326 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Alkylamides from Echinacea Are a New Class of Cannabinomimetics

Stefan Raduner, Adriana Majewska, Jian‐Zhong Chen et al. · Journal of Biological Chemistry · 2006 · 256 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data

Jacques Hamon, Bernard Faller, Steven Whitebread et al. · ChemMedChem · 2007 · 177 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13